+39.4% · 90d
$2.83
-0.05 (-1.74%)
News
(1)April 2026
CCCC Highlights Protein Degradation Pipeline in 2026 Vision Deck
CCCCC4 Therapeutics, Inc.
# 🧾 What This Document Is This is a **Form 8-K**, a current report that public companies must file with the SEC to announce major events that shareholders should know about. Think of it as a real-time news alert system. In this case, C4 Therapeutics has uploaded a corporate slide deck titled "Prote
Read summaryView on SEC EDGAR
Peers in Biotechnology
VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%